| Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Lu L.F., Thai T.H., Calado D.P., Chaudhry A., Kubo M., Tanaka K., Loeb G.B., Lee H., Yoshimura A., Rajewsky K. et al.
Immunity 30:80-91(2009) · Mapped (3) |
| Transplantation survival is maintained by granzyme B+ regulatory cells and adaptive regulatory T cells. Gondek D.C., Devries V., Nowak E.C., Lu L.F., Bennett K.A., Scott Z.A., Noelle R.J.
J. Immunol. 181:4752-4760(2008) · Mapped (6) |
| Dicer-dependent microRNA pathway safeguards regulatory T cell function. Liston A., Lu L.F., O'Carroll D., Tarakhovsky A., Rudensky A.Y.
J. Exp. Med. 205:1993-2004(2008) · Mapped (8) |
| G protein-coupled receptor 83 is dispensable for the development and function of regulatory T cells. Lu L.F., Gavin M.A., Rasmussen J.P., Rudensky A.Y.
Mol. Cell. Biol. 27:8065-8072(2007) · Mapped (4) |
| The in vivo function of a noncanonical TRAF2-binding domain in the C-terminus of CD40 in driving B-cell growth and differentiation. Lu L.F., Ahonen C.L., Lind E.F., Raman V.S., Cook W.J., Lin L.L., Noelle R.J.
Blood 110:193-200(2007) · Mapped (7) |
| Mast cells are essential intermediaries in regulatory T-cell tolerance. Lu L.F., Lind E.F., Gondek D.C., Bennett K.A., Gleeson M.W., Pino-Lagos K., Scott Z.A., Coyle A.J., Reed J.L., Van Snick J. et al.
Nature 442:997-1002(2006) · Mapped (8) |
| NF kappa B-inducing kinase deficiency results in the development of a subset of regulatory T cells, which shows a hyperproliferative activity upon glucocorticoid-induced TNF receptor family-related gene stimulation. Lu L.F., Gondek D.C., Scott Z.A., Noelle R.J.
J. Immunol. 175:1651-1657(2005) · Mapped (3) |
| Comparative and functional genomic analyses of the pathogenicity of phytopathogen Xanthomonas campestris pv. campestris. Qian W., Jia Y., Ren S.-X., He Y.-Q., Feng J.-X., Lu L.-F., Sun Q., Ying G., Tang D.-J., Tang H. et al.
Genome Res. 15:757-767(2005) · UniProtKB (4,239) |
| Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. Gondek D.C., Lu L.F., Quezada S.A., Sakaguchi S., Noelle R.J.
J. Immunol. 174:1783-1786(2005) · Mapped (4) |
| CD40 signaling through a newly identified tumor necrosis factor receptor-associated factor 2 (TRAF2) binding site. Lu L.F., Cook W.J., Lin L.L., Noelle R.J.
J. Biol. Chem. 278:45414-45418(2003) · Mapped (7) |
| Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing. Ren S.-X., Fu G., Jiang X.-G., Zeng R., Miao Y.-G., Xu H., Zhang Y.-X., Xiong H., Lu G., Lu L.-F. et al.
Nature 422:888-893(2003) · UniProtKB (4,690) |
| Variant-type PML-RAR(alpha) fusion transcript in acute promyelocytic leukemia: use of a cryptic coding sequence from intron 2 of the RAR(alpha) gene and identification of a new clinical subtype resistant to retinoic acid therapy. Gu B.W., Xiong H., Zhou Y., Chen B., Wang L., Dong S., Yu Z.Y., Lu L.F., Zhong M., Yin H.F. et al.
Proc. Natl. Acad. Sci. U.S.A. 99:7640-7645(2002) · Mapped (20) |
in Literature Citations
